Balyasny Asset Management LLC Bridge Bio Pharma, Inc. Call Options Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $1.67 Million - $2.19 Million	69,900 New	69,900 $1.78 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $198,500 - $309,000	25,000 New	25,000 $249,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $554,206 - $2.6 Million	48,700 New	48,700 $812,000
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $2.77 Million - $3.62 Million	-50,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $1.92 Million - $3.56 Million	50,000 New	50,000 $3.56 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.57B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.